Skip to main content

Year: 2025

KANZHUN LIMITED Announces Upsizing and Extension of Share Repurchase Program

BEIJING, Aug. 20, 2025 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced the upsizing and extension of its share repurchase program. As previously announced, the Company established a share repurchase program on August 29, 2024, whereby the Company was authorized to repurchase up to US$150 million of its shares (including in the form of American depositary shares (“ADS”)) for a 12-month period. On August 20, 2025, the Company’s board of directors approved amendments to its existing share repurchase program, extending the program for a 12-month period through August 28, 2026 and authorizing repurchases of up to US$250 million of the Company’s shares (including ADSs) during the extended 12-month period. Safe Harbor Statement This...

Continue reading

YieldMax® ETFs Announces Distributions on FIAT, ULTY, AMDY, CVNY, HOOY, and Others

CHICAGO, MILWAUKEE and NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) — YieldMax® today announced distributions for the YieldMax® Weekly Payers and Group C ETFs listed in the table below.ETF Ticker1 ETF Name Distribution Frequency Distribution per Share Distribution Rate2,4 30-DaySEC Yield3 ROC5 Ex-Date & Record Date Payment Date  CHPY YieldMax® Semiconductor Portfolio Option Income ETF Weekly $ 0.3993 39.23 % 0.00 % 100.00 % 8/21/25 8/22/25  GPTY YieldMax® AI & Tech Portfolio Option Income ETF Weekly $ 0.3077 36.05 % 0.00 % 100.00 % 8/21/25 8/22/25  LFGY YieldMax® Crypto Industry & Tech Portfolio Option Income ETF Weekly $ 0.4127 61.10 % 0.00 % 100.00 % 8/21/25 8/22/25  QDTY YieldMax® Nasdaq 100 0DTE Covered Call ETF Weekly $ 0.1912 22.37 % 0.00 % 84.85 % 8/21/25 8/22/25  RDTY YieldMax® R2000 0DTE Covered...

Continue reading

KANZHUN LIMITED Announces Board Changes and Appointment of President

BEIJING, Aug. 20, 2025 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced that Ms. Mengyuan Dong has resigned as an independent non-executive director of the Company in order to devote more time to her other personal business commitments, effective on August 20, 2025. In addition, with effect from August 20, 2025, Ms. Hongyu Liu, an independent non-executive director and a member of the nomination committee has been appointed as the chairman of the audit committee and a member of the corporate governance committee. Mr. Yan Li, an independent non-executive director, the chairman of the nomination committee, the chairman of the corporate governance committee, and a member of the audit committee, has been appointed as a member...

Continue reading

Gilat Awarded Over $60 Million for Stellar Blu ESA Sidewinder Terminals

Orders mark milestone for Gilat’s linefit ESA strategy, driving in-flight connectivity expansion PETAH TIKVA, Israel, Aug. 20, 2025 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that its Commercial Division has been awarded more than $60 million in orders from a leading satellite operator for its Stellar Blu ESA Sidewinder in-flight connectivity terminals. Deliveries are expected in the next 12 months. These orders, for hundreds of additional Sidewinder ESA terminals, support new airline fleet awards in retrofit and the first production run of Sidewinders for the eventual OEM linefit terminal for Boeing. “The Stellar Blu Sidewinder ESA is redefining airborne connectivity with the performance and flexibility...

Continue reading

Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference

DEER PARK, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the Company’s executive leadership team will host 1×1 meetings at the 2025 Wells Fargo Healthcare Conference being held September 3-5, 2025 in Boston, MA. To schedule a 1×1 meeting with the Company, please contact your Wells Fargo institutional sales representative. About Eton Pharmaceuticals Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has eight commercial rare disease products: KHINDIVI™, INCRELEX®, ALKINDI SPRINKLE®, GALZIN®, PKU GOLIKE®, Carglumic Acid, Betaine...

Continue reading

Brookfield Corporation Announces Renewal of Normal Course Issuer Bid for Preferred Shares

BROOKFIELD, NEWS, Aug. 20, 2025 (GLOBE NEWSWIRE) — Brookfield Corporation (TSX: BN, NYSE: BN) (“Brookfield” or “the Company”) today announced it has received approval from the Toronto Stock Exchange (“TSX”) for the renewal of its normal course issuer bid to purchase up to 10% of the public float of each series of the Company’s outstanding Class A Preference Shares that are listed on the TSX (the “Preferred Shares”). Purchases under the bid will be made on the open market through the facilities of the TSX and/or alternative Canadian trading systems. The period of the normal course issuer bid will extend from August 22, 2025 to August 21, 2026, or an earlier date should Brookfield complete its purchases. Brookfield will pay the market price at the time of acquisition for any Preferred Shares purchased or such other price as may be...

Continue reading

Sono Group N.V. Reports Second Quarter and First Half 2025 Results: Net Income of €8.0 Million for H1 and Continued Commercial Momentum in Solar Mobility

H1 2025 net income of €8.0 million primarily driven by fair value adjustments; disciplined cost base and improved operating cash use; progress on OEM collaborations and brand architecture MUNICH, Aug. 20, 2025 (GLOBE NEWSWIRE) — Sono Group N.V. (OTCQB: SEVCF) (hereafter referred to as “Sono” or the “Company”, parent company to Sono Motors GmbH, hereafter referred to as “SonoSolar” or “Subsidiary”), the solar technology company, today announced its financial results for the second quarter ended June 30, 2025 and the first half of 2025. H1 2025 Financial Highlights                                                                                Net income of €8.0 million, reflecting primarily gains from fair value changes in convertible notes; Q2 2025 net loss of €0.8 million, a 44% reduction in net loss from Q2 2024. Cash used in...

Continue reading

Jiayin Group Inc. Reports Second Quarter 2025 Unaudited Financial Results

— Second Quarter Total Loan Facilitation Volume Grew 54.6% to RMB37.1 billion —— Second Quarter Net Revenue Grew 27.8% to RMB1,886.2 million — SHANGHAI, China, Aug. 20, 2025 (GLOBE NEWSWIRE) — Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Operational and Financial Highlights:Loan facilitation volume1 was RMB37.1 billion (US$5.2 billion), representing an increase of 54.6% from the same period of 2024.Average borrowing amount per borrowing was RMB8,130 (US$1,135), representing a decrease of 10.5% from the same period of 2024.Repeat borrower contribution2 of total loan facilitation volume was 75.6%, compared with 73.4% in the same period...

Continue reading

T1 Energy Reports Second Quarter 2025 Results

G1 DallasT1 Energy’s G1 Dallas Solar Cell Manufacturing FacilityAUSTIN, Texas and NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) — T1 Energy Inc. (NYSE: TE) (“T1,” “T1 Energy,” or the “Company”) has reported financial and operating results for the second quarter 2025 and will hold a conference call today. HeadlinesT1 announces transformative agreement with Corning Incorporated. T1 signed a deal to purchase solar wafers produced by Corning Incorporated (NYSE: GLW) in Michigan, which advances the Company’s FEOC compliance effort, boosts development of a domestic solar supply chain and is expected to position T1 as a preeminent supplier of American solar modules at a time of rising demand. T1 signed a 437 MW 2025 sales agreement with one of the largest U.S. utilities. The Company has been fielding a noticeably elevated...

Continue reading

H World Group Limited Reports Second Quarter and Interim of 2025 Unaudited Financial Results

A total of 12,137 hotels or 1,184,915 hotel rooms in operation as of June 30, 2025. Hotel turnover1 increased 15.0% year-over-year to RMB26.9 billion in the second quarter of 2025. Excluding Steigenberger Hotels GmbH and its subsidiaries (“DH”, or “Legacy-DH”), hotel turnover increased 15.6% year-over-year in the second quarter of 2025. Hotel turnover from the Legacy-DH segment increased 8.9% in the second quarter of 2025. Revenue increased 4.5% year-over-year to RMB6.4 billion (US$897 million)2 in the second quarter of 2025, near the high end of the revenue guidance previously announced of a 1% to 5% increase compared to the second quarter of 2024. Manachised and franchised revenue increased 22.8% year-over-year to RMB2.9 billion (US$400 million) in the second quarter of 2025, exceeding the high end of the manachised and franchised revenue...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.